Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). A formatting tweak changes 'Intervention / Treatment' to 'Intervention/Treatment' and the revision label updated to Revision: v3.6.0.SummaryDifference0.2%

- Check18 days agoChange DetectedThe page’s footer revision label changed from v3.5.4 to v3.5.5, indicating an updated site release. This is an internal metadata update and does not alter the study details or other user-facing content on the page.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page revision has been updated to v3.5.4. This indicates an updated site version rather than any modification to the study data or content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing Revision: v3.5.2, signaling a front-end/site version update. This change is administrative and does not modify the study data or visible content.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 was removed, indicating a minor software update.SummaryDifference0.0%

- Check76 days agoChange DetectedDifference0.0%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.